The New Game of 'Backdoor Listing': Investors Sound Alarm Over Exploitation of Regulatory Loopholes
Market analysts have raised serious concerns with SEBON regarding Om Megashree Pharmaceuticals Limited's…Market analysts have raised serious concerns with SEBON regarding Om Megashree Pharmaceuticals Limited's proposed acquisition of an unlisted private company, warning against backdoor listings and regulatory exploitation.